Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 7, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Sleeve lobectomy: current indications and future directions.

Jarrod D Predina1, Meghana Kunkala, Louis A Aliperti

  • 1University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

Annals of Thoracic and Cardiovascular Surgery : Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia
|October 30, 2010
PubMed
Summary

Sleeve lobectomy is now a primary treatment for central lung lesions, offering better long-term outcomes than pneumonectomy. Advances make this surgical technique increasingly favorable for more patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

Fibroblast activation protein-targeted near-infrared labeling of cancer-associated fibroblasts in a non-small-cell lung cancer tumor microenvironment.

Scientific reports·2026
Same author

Intraoperative Nodule Localization in Non-Small-Cell Lung Cancer: Existing and Emerging Techniques.

Cancers·2026
Same author

Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis.

Clinical lung cancer·2026
Same author

3D Reactive Oxygen Species Dosimetry in Pleural Photodynamic Therapy: Integration of Macroscopic Kinetic Modeling and Deformable Registration.

Antioxidants (Basel, Switzerland)·2026
Same author

Translational development of an SGLT2-targeted near-infrared contrast agent for intraoperative imaging of early-stage lung cancer.

EJNMMI research·2026

Area of Science:

  • Thoracic surgery
  • Pulmonary medicine
  • Surgical oncology

Background:

  • Sleeve lobectomy was initially a compromise for patients with limited cardiopulmonary reserve.
  • Centrally located lung lesions posed significant surgical challenges.

Purpose of the Study:

  • To evaluate the evolution and current role of sleeve lobectomy in treating centrally located lung lesions.
  • To compare sleeve lobectomy with pneumonectomy and other procedures.

Main Methods:

  • Review of current literature on sleeve lobectomy outcomes.
  • Analysis of patient selection criteria and surgical technique advancements.
  • Comparison of long-term results and cost-effectiveness.

Main Results:

More Related Videos

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
11:17

Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer

Published on: February 27, 2026

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection
07:22

Laparoscopic Left Hemihepatectomy Combined with Caudate Lobe Resection

Published on: April 11, 2025

  • Sleeve lobectomy has evolved into a first-line intervention for central lung lesions of all grades.
  • It demonstrates superior long-term outcomes and cost-effectiveness compared to pneumonectomy.
  • Its application has expanded to locally advanced disease with favorable results.

Conclusions:

  • Sleeve lobectomy is a preferred and effective treatment for selected lung cancer patients.
  • Neoadjuvant therapy and minimally invasive approaches further enhance its utility.
  • Future advancements are expected to increase its attractiveness as a treatment option.